Federal grant · project grant (b)
Fingerprinting Cancer via Multiparameter Extracellular Vesicle Analysis - Project Summary Electronic Biosciences (EBS) Proposes, in Collaboration With Distinguished Professor Henry White at the University of Utah, to Develop a Nanopore-based Extracellular Vesicle (EV) Characterization System Capable of High-resolution, Single-vesicle, Solution-based Characterization, Sorting, and Isolation. Evs Are Nanometer-scale, Cell-derived Vesicles That Are Produced by Nearly All Mammalian Cells Under Normal Physiological Conditions and With Increased Production Rates for Various Disease States (e.g. Cancers, Neurological Diseases, Psychiatric Disorders, Etc.). Evs Can Be Found in Most Biological Fluids and Contain Proteins, Nucleic Acids, and Lipid Molecules That Are Distinctly Dissimilar to the Parent Cell’s Cytoplasmic Contents, Indicating That Exosome Loading Is Not a Diffusive or Unregulated Process. Furthermore, Evs Facilitate Intercellular Communication by Transferring These Contents Into Recipient Cells to Alter the Target Cells’ Phenotype and Function. Thus, in Addition to Their General Physiological Roles, Evs Have Important Implications in Disease Pathogenesis, and Significant Potential as Therapeutic Targets and Drug Carriers. Consequently, This Has Spurred a Great Deal of Interest in New Methods to Not Only Characterize the Physical Properties of Evs (size, Zeta Potential, Surface Markers, Nucleic Acid Cargo, and Concentration), But Increased Interest in Developing New Techniques That Have the Ability to Efficiently and Accurately Sort/isolate Evs Such That the Contents/cargo Can Be Profiled in a Subpopulation-specific Manner. Advances in the Areas of Ev Characterization and Sorting/isolation Would Greatly Assist the Efforts to Understand the General Role of Evs in Human Health, and Also Benefit Efforts Aimed at Utilizing Evs in Molecular Diagnostics, Biomarker Identification, and Targeted Therapies for Cancer. the Ev Characterization and Sorting System That Ebs and Professor Henry White Will Be Developing During This Program Will Specifically Enable Single-particle Assessments of an Ev Sample’s True Distribution of Size, Zeta Potential, Density of Fluorescently Tagged Surface Markers, and Nucleic Acid Cargo, Along With the Ability to Isolate/collect Specific Ev Subpopulations With Tightly Defined Biophysical Parameters, All on a Single Platform. the Feasibility of the Proposed System Will Be Demonstrated by Building a Prototype Platform and Showing Its Ability to Characterize, Sort and Isolate Ev Samples. the Resulting System Will Have an Ease-of-use, Throughput, and Price Point Similar to Flow Cytometry, Dynamic Light Scattering (DLS), Nanoparticle Tracking Analysis (nta), or Single-pass Resistive-pulse Techniques, With a Resolution Comparable to Microscopy Techniques, E.g. Scanning or Tunneling Electron Microscopy (sem or Tem, Respectively) or Atomic Force Microscopy (afm), Yielding a State-of-the-art Instrument Which Will Directly Enable and Advance the Field of Ev Diagnostics.
Committed
$400,000
Paid out
$365.6K
91%
Committed, not yet paid
$34.4K
9%
Loading…
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then unspent ceiling.